http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007045420-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fadda8291adce4080fa1a0e3b80ea853
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a70b05f3bdf7f6e9aaf7a41ac3aacdc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c2c6e3f57ee34131352877fef10289fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_46f08345cfdca6137a9359083987111c
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C271-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-32
filingDate 2006-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_543b175d8184efaeb45751b5df511fc3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d2f29ffeccac73b99353da17015de52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e07fe76dc8b8e6debc73a381a9cf253
publicationDate 2007-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2007045420-A3
titleOfInvention 3-alkyl-5- (4-alkyl-5-oxo-tetrahydrofutran-2-yl) pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors
abstract The invention related to a novel process, novel process steps and novel intermediates useful in the synthesis of pharmaceutically active compounds, especially renin inhibitors, such as Aliskiren. Inter alia, the invention relates to a process for the manufacture of a compound of the formula II, or a salt thereof, and a compound of formula Vl or a salt thereof, wherein R3 and R4 as well as Act are as defined in the specification, and processes of manufacturing these. Additionally transformation of compounds (Vl) with metallo organic compounds (VII) give rise to the new compounds (VMI) which are direct precursors for the preparation of Aliskiren.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102775393-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102775393-B
priorityDate 2005-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006024501-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0678503-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005051895-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006131304-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229208319
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68535994
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226490589
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12025
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87068638
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492437
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521561
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5493444
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6547

Total number of triples: 43.